Licensing agreements between pharmaceutical companies and the Medicines Patent Pool, in cooperation with the WHO, could accelerate access to doses for the poorest countries.
The US and China have reportedly agreed on a partial deal to ease tensions in the two-year old trade war. Does that mean it’s almost over? Fat chance, an economist says.
Intelligence officials in many countries are concerned the company could be helping the Chinese government spy on companies, military units and government agencies.
The ongoing NAFTA renegotiations could put a Canadian national pharmacare program in jeopardy, and have a particular impact on Canadians who need expensive arthritis drugs. Here’s how.
Canola is an example of an innovation that sprung from university research and became a major economic boon to Canada. It should be happening more often.
China established a system of approving foreign investments on condition the businesses involved agreed to partner with local firms and transfer knowledge and skills to the local Chinese market.
Even though Australia sides with the US on more areas of policy, it should be careful about being dragged into the back-and-forth of sanctions between the US and China.
Alexandra Sims, University of Auckland, Waipapa Taumata Rau
Blockchain technology is flourishing in an open-source environment, which raises the question of whether current intellectual property laws are the best tools to foster innovation.
Amazon this week purchased the global rights to J.R.R. Tolkein’s The Lord of the Rings to turn it into a television series. What are the implications for Australia’s content and its global reach?